Question 1

Does BNP Paribas Financial Markets own BBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BNP Paribas Financial Markets holds 1,155,442 shares of BBIO (BridgeBio Pharma), worth $86.1M.

Question 2

How many shares of BBIO does BNP Paribas Financial Markets own?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets holds 1,155,442 shares of BBIO (BridgeBio Pharma).

Question 3

What is BNP Paribas Financial Markets' BBIO position worth?

Accepted Answer

As of its Q2 2026 13F, BNP Paribas Financial Markets' BBIO position is worth $86.1M.

Question 4

Is BNP Paribas Financial Markets buying or selling BBIO?

Accepted Answer

In Q2 2026, BNP Paribas Financial Markets reduced its BBIO position by 151,734 shares (-11.6%).

Question 5

When did BNP Paribas Financial Markets first buy BBIO?

Accepted Answer

BNP Paribas Financial Markets first reported BBIO in its Q3 2019 13F and has listed it in 27 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.2M	-11.6%	$86.1M	0.0%	$74.48	0
2026-Q1	Decreased	1.3M	-17.9%	$97.1M	0.0%	$74.26	0
2025-Q4	Increased	1.6M	+149.1%	$121.8M	0.1%	$76.49	49
2025-Q3	Increased	639,264	+45.6%	$33.2M	0.0%	$51.94	39
2025-Q2	Increased	439,066	+39.5%	$19M	0.0%	$43.18	38
2025-Q1	Increased	314,702	+1148.3%	$10.9M	0.0%	$34.57	45
2024-Q4	Decreased	25,210	-33.7%	$691,762	0.0%	$27.44	0
2024-Q3	Increased	38,039	+186.0%	$968,473	0.0%	$25.46	40